Clinical trials
Muscular Atrophy trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| University Hospital, Montpellier | 3 |
| Scholar Rock, Inc. | 2 |
| Association Pro-arte | 1 |
| CHU de Reims | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Centre Hospitalier de Saint-Brieuc | 1 |
| Direction Centrale du Service de Santé des Armées | 1 |
| Eli Lilly and Company | 1 |
| Nantes University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 23 |
| Muscular Atrophy, Spinal | 6 |
| Atrophy | 3 |
| Bulbo-Spinal Atrophy, X-Linked | 3 |
| Muscular Diseases | 3 |
| Neuromuscular Diseases | 3 |
| Inflammation | 2 |
| Muscle Weakness | 2 |
| Myositis, Inclusion Body | 2 |
| Neuromuscular Manifestations | 2 |
Trials
Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.